Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06298084
Status:
RECRUITING
Last Update Posted:
2024-03-29
First Post:
2024-02-12
Brief Title:
Dose-Expansion Modular Study To Explore the Safety Tolerability and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer ABC After Progression on T-DXd
Sponsor:
Gustave Roussy Cancer Campus Grand Paris
Organization:
Gustave Roussy Cancer Campus Grand Paris
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Breast Cancer |
| Breast Cancer Metastatic |
| HER2-positive Metastatic Breast Cancer |
| HER2 Low Breast Carcinoma |
Keywords: